Drug Repurposing Market Is Gaining Huge Growth In Upcoming Years

Drug repurposing is also known as drug repositioning. It is a process of identifying new therapeutic use(s) for old/existing/available drugs. It is an effective strategy in developing or discovering drug molecules with new therapeutic indications. In recent years, many pharmaceutical companies are developing new drugs with the discovery of novel biological targets by applying the drug repositioning strategy in drug discovery and development programs.

Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00016853/?utm_source=OpenPR&utm_medium=10129

This strategy is highly efficient, low-cost, time-saving, and minimum risk of failure. It increases the therapeutic value of a drug and consequently maximizes the success rate. Drug repositioning is thus an important alternative method to the conventional process of drug development.

Drug Repurposing Market: Competitive Landscape and Key Developments
• Astellas Pharma Inc.
• Biovista
• Novartis AG
• AbbVie Inc.
• Pfizer Inc.
• Allergan Plc.
• NuMedii
• Abbott Healthcare
• Hoffmann-La Roche
• Johnson & Johnson.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.